TherapeuticsMD Inc. (TXMD)

2.59
NASDAQ : Health Technology
Prev Close 2.66
Day Low/High 2.54 / 2.73
52 Wk Low/High 2.21 / 7.34
Avg Volume 3.30M
Exchange NASDAQ
Shares Outstanding 241.22M
Market Cap 641.65M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

TherapeuticsMD To Host Investor And Analyst Day Today

TherapeuticsMD To Host Investor And Analyst Day Today

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, will host its Investor and Analyst Day today in New York City.

TherapeuticsMD And Theramex Enter Into Exclusive License And Supply Agreement To Commercialize BIJUVA™ And IMVEXXY® Outside The United States

TherapeuticsMD And Theramex Enter Into Exclusive License And Supply Agreement To Commercialize BIJUVA™ And IMVEXXY® Outside The United States

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it has entered into an exclusive license and supply agreement with Theramex, a leading, global specialty pharmaceutical company dedicated to...

TherapeuticsMD To Host Investor And Analyst Day On June 10, 2019 In New York City

TherapeuticsMD To Host Investor And Analyst Day On June 10, 2019 In New York City

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women's healthcare company, today announced that it will host an Investor and Analyst Day on Monday, June 10, 2019, in New York City.

Interesting TXMD Put And Call Options For July 19th

Interesting TXMD Put And Call Options For July 19th

Investors in TherapeuticsMD Inc saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TXMD options chain for the new July 19th contracts and identified one put and one call contract of particular interest.

TherapeuticsMD Announces Participation At The Bank Of America Merrill Lynch 2019 Health Care Conference

TherapeuticsMD Announces Participation At The Bank Of America Merrill Lynch 2019 Health Care Conference

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that the company will participate in the Bank of America Merrill Lynch 2019 Health Care Conference.

TherapeuticsMD Announces First Quarter 2019 Financial Results

TherapeuticsMD Announces First Quarter 2019 Financial Results

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced its commercial and corporate update for the first quarter ended March 31, 2019.

TherapeuticsMD Presented New Research At The American College Of Obstetricians And Gynecologists 2019 Annual Meeting That Explores How Women's Menopausal Symptoms Affect Men

TherapeuticsMD Presented New Research At The American College Of Obstetricians And Gynecologists 2019 Annual Meeting That Explores How Women's Menopausal Symptoms Affect Men

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the presentation of results from the Men's Attitude Toward Menopause Survey (MATE), a large study of men's understanding of and attitudes related to...

TherapeuticsMD Announces Oral And Poster Presentations On BIJUVA™ And ANNOVERA™ At The American College Of Obstetricians And Gynecologists 2019 Annual Meeting

TherapeuticsMD Announces Oral And Poster Presentations On BIJUVA™ And ANNOVERA™ At The American College Of Obstetricians And Gynecologists 2019 Annual Meeting

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the schedule of presentations on BIJUVA TM (estradiol and progesterone capsules, 1 mg/100 mg) and ANNOVERA™ (segesterone acetate/ethinyl estradiol...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TherapeuticsMD, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TherapeuticsMD, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

NEW YORK, May 2, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of TherapeuticsMD,...

Interesting TXMD Put And Call Options For December 20th

Interesting TXMD Put And Call Options For December 20th

Investors in TherapeuticsMD Inc saw new options begin trading this week, for the December 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TherapeuticsMD To Report First Quarter 2019 Results On May 6, 2019

TherapeuticsMD To Report First Quarter 2019 Results On May 6, 2019

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that it will report its first quarter 2019 financial results on Monday, May 6, 2019, after the closing of the U.

TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility With TPG Sixth Street Partners

TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility With TPG Sixth Street Partners

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women's healthcare company, today announced that it has closed its previously disclosed $300 million non-dilutive secured term loan financing facility with TPG Sixth Street Partners ("TSSP"), the...

TherapeuticsMD Signs Binding Commitment Letter For $300 Million Non-Dilutive Term Loan Financing Facility With TPG Sixth Street Partners

TherapeuticsMD Signs Binding Commitment Letter For $300 Million Non-Dilutive Term Loan Financing Facility With TPG Sixth Street Partners

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women's healthcare company, today announced that it has signed a binding commitment letter for a fully-negotiated $300 million non-dilutive secured term loan financing facility with TPG Sixth...

TherapeuticsMD Announces Commercial Availability Of BIJUVA™ In The U.S.

TherapeuticsMD Announces Commercial Availability Of BIJUVA™ In The U.S.

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the commercial availability of BIJUVA TM (estradiol and progesterone capsules, 1 mg/100 mg) in the United States.

TherapeuticsMD Announces Oral And Poster Presentations On BIJUVA™ And ANNOVERA™ At The Endocrine Society 2019 Annual Meeting

TherapeuticsMD Announces Oral And Poster Presentations On BIJUVA™ And ANNOVERA™ At The Endocrine Society 2019 Annual Meeting

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the schedule of presentations on BIJUVA™ (estradiol and progesterone capsules, 1 mg/100 mg) and ANNOVERA™ (segesterone acetate/ethinyl estradiol...

TherapeuticsMD Announces Oral Presentations On BIJUVA And ANNOVERA, And Poster Presentations Related To Menopause Symptoms And Treatments At 2019 ISSWSH/ISSM Joint Meeting

TherapeuticsMD Announces Oral Presentations On BIJUVA And ANNOVERA, And Poster Presentations Related To Menopause Symptoms And Treatments At 2019 ISSWSH/ISSM Joint Meeting

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the schedule of oral presentations on clinical data for BIJUVA TM (estradiol and progesterone capsules, 1 mg/100 mg) and ANNOVERA TM (segesterone...

TherapeuticsMD Announces Participation In Two Upcoming Investor Conferences

TherapeuticsMD Announces Participation In Two Upcoming Investor Conferences

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that the company will participate in two upcoming healthcare conferences.

TherapeuticsMD Announces Fourth Quarter And Full-Year 2018 Financial Results

TherapeuticsMD Announces Fourth Quarter And Full-Year 2018 Financial Results

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women's healthcare company, today announced its commercial and corporate update for the fourth quarter and full-year ended December 31, 2018.

TherapeuticsMD To Report Fourth Quarter And Full Year 2018 Results On February 21, 2019

TherapeuticsMD To Report Fourth Quarter And Full Year 2018 Results On February 21, 2019

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that it will report its fourth quarter and full year 2018 financial results on Thursday, February 21, 2019, after the closing of the U.

Box, Cummins, Verizon: 'Mad Money' Lightning Round

Box, Cummins, Verizon: 'Mad Money' Lightning Round

Jim Cramer is taking a closer look at Box, Cummins, Verizon, TherapeuticsMD, Morgan Stanley, Canopy Growth, Principal Financial and more.

Don't Be A Hero: Cramer's 'Mad Money' Recap (Thursday 2/7/19)

Don't Be A Hero: Cramer's 'Mad Money' Recap (Thursday 2/7/19)

Don't get too bearish, says Jim Cramer, but don't break discipline here. This is a perfectly reasonable decline.

First Week Of February 15th Options Trading For TherapeuticsMD (TXMD)

First Week Of February 15th Options Trading For TherapeuticsMD (TXMD)

Investors in TherapeuticsMD Inc saw new options begin trading this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TXMD options chain for the new February 15th contracts and identified one put and one call contract of particular interest.

TherapeuticsMD Announces Participation At 37th Annual J.P. Morgan Healthcare Conference

TherapeuticsMD Announces Participation At 37th Annual J.P. Morgan Healthcare Conference

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the company will participate in the 37 th Annual J.

The Charts of TherapeuticsMD Look Bearish to Me

The Charts of TherapeuticsMD Look Bearish to Me

In the daily bar chart of TherapeuticsMD we can see that prices are in a downtrend from June.

Hormel, Medtronic, Cisco and More: 'Mad Money' Lightning Round

Hormel, Medtronic, Cisco and More: 'Mad Money' Lightning Round

Jim Cramer weighs in on Hormel, Medtronic, Cisco and more.

The Fed Is Wrong: Cramer's 'Mad Money' Recap (Thursday 12/20/18)

The Fed Is Wrong: Cramer's 'Mad Money' Recap (Thursday 12/20/18)

Jim Cramer says the market pain will eventually end, once the Fed sees the error of its ways.

Relative Strength Alert For TherapeuticsMD

Relative Strength Alert For TherapeuticsMD

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TherapeuticsMD Announces Participation In Three Upcoming Investor Conferences

TherapeuticsMD Announces Participation In Three Upcoming Investor Conferences

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the company will participate in three upcoming healthcare investor conferences.

TheStreet Quant Rating: D- (Sell)